Voice your opinion on congressional bill S4199-116 and let lawmakers know your stance with UnPac!

Main Subject: Health

Prescription Drug Pricing Reduction Act of 2020

This bill alters several programs and requirements relating to the prices of prescription drugs under Medicare and Medicaid.

Among other things, the bill

requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for certain drugs covered under Medicare for which the average manufacturer price increases faster than inflation;
requires drug manufacturers to issue rebates to the CMS for discarded amounts of certain single-dose drugs covered under Medicare, based on information reported by providers;
reduces the annual out-of-pocket spending threshold, and eliminates beneficiary cost-sharing above this threshold, under the Medicare prescription drug benefit;
requires the CMS to publish certain information, as reported by pharmacy benefit managers (PBMs), relating to drug discounts and rebates, and payments between PBMs, health plans, and pharmacies;
requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid; and
increases the maximum rebate payable by drug manufacturers under the Medicaid Drug Rebate Program.

HR1264-116, HR1781-116, HR3029-116, HR4629-116, HR4649-116, HR5281-116, HR5882-116, S801-116, S1505-116, S1999-116, S2543-116,

Accounting and auditing Administrative law and regulatory procedures Advisory bodies Congressional oversight Department of Health and Human Services Drug safety, medical device, and laboratory regulation Drug therapy Emergency medical services and trauma care Fraud offenses and financial crimes Genetics Government information and archives Government studies and investigations Health care costs and insurance Health care coverage and access Health care quality Health information and medical records Health programs administration and funding Health technology, devices, supplies Drug safety medical device and laboratory regulation Health technology devices supplies Health

IntroReferral
Jul. 02 2020	Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4228)

IntroReferral
Jul. 02 2020	Introduced in Senate